Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rashmi R Shah

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Novartis Foundation Symposium|July 30, 2005
Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studiesRashmi R Shah
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics in drug regulation: promise, potential and pitfallsRashmi R Shah
Drug Safety|February 10, 2017
Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?Rashmi R Shah
Clinical Genitourinary Cancer|August 16, 2016
Comment on: Bono P, Oudard S, Bodrogi I, et al. Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials. Clin Genitourin Cancer 2016Rashmi R Shah
Drug Safety|August 19, 2016
Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic DilemmasRashmi R Shah
Drug Safety|February 6, 2004
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribingRashmi R Shah
British Journal of Clinical Pharmacology|August 14, 2012
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?Rashmi R Shah
Drug Safety|February 5, 2005
Drugs, QT interval prolongation and ICH E14: the need to get it rightRashmi R Shah
Drug Safety|October 20, 2005
Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges aheadRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|October 13, 2018
Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?Rashmi R Shah
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Novartis Foundation Symposium|July 30, 2005
Drug-induced QT interval prolongation--regulatory guidance and perspectives on hERG channel studiesRashmi R Shah
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|August 13, 2005
Pharmacogenetics in drug regulation: promise, potential and pitfallsRashmi R Shah
Drug Safety|February 10, 2017
Anti-Angiogenic Tyrosine Kinase Inhibitors and Reversible Posterior Leukoencephalopathy Syndrome: Could Hypomagnesaemia Be the Trigger?Rashmi R Shah
Clinical Genitourinary Cancer|August 16, 2016
Comment on: Bono P, Oudard S, Bodrogi I, et al. Outcomes in Patients With Metastatic Renal Cell Carcinoma Who Develop Everolimus-Related Hyperglycemia and Hypercholesterolemia: Combined Subgroup Analyses of the RECORD-1 and REACT Trials. Clin Genitourin Cancer 2016Rashmi R Shah
Drug Safety|August 19, 2016
Tyrosine Kinase Inhibitor-Induced Interstitial Lung Disease: Clinical Features, Diagnostic Challenges, and Therapeutic DilemmasRashmi R Shah
Drug Safety|February 6, 2004
Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribingRashmi R Shah
British Journal of Clinical Pharmacology|August 14, 2012
Drug-induced QT interval prolongation: does ethnicity of the thorough QT study population matter?Rashmi R Shah
Drug Safety|February 5, 2005
Drugs, QT interval prolongation and ICH E14: the need to get it rightRashmi R Shah
Drug Safety|October 20, 2005
Drugs, QTc interval prolongation and final ICH E14 guideline : an important milestone with challenges aheadRashmi R Shah
Journal of Clinical Pharmacy and Therapeutics|October 13, 2018
Metamizole (dipyrone)-induced agranulocytosis: Does the risk vary according to ethnicity?Rashmi R Shah
Pageof 6